Nanotechnology Now - Press Release: "Nanobubbles Deliver Targeted Cancer Drugs Using Ultrasound"

Home > Press > Nanobubbles Deliver Targeted Cancer Drugs Using Ultrasound

Abstract:
Using a combination of polymers that respond to temperature, a research team at the University of Utah has developed a multifunctional nanoparticle that can image tumors using ultrasound and simultaneously deliver cell-damaging energy and anticancer drugs to those tumors. In addition, these nanoparticles appear to act specifically on tumors and not on healthy tissue.

Nanobubbles Deliver Targeted Cancer Drugs Using Ultrasound

Bethesda, MD | Posted on September 27th, 2008

Reporting its work in the journal Ultrasonics, a research team headed by Natalya Rapoport, D.Sc., describes its development of nanoparticles designed to turn into larger microscale bubbles at body temperature. These nanoparticles are made of perfluorocarbons, which interact strongly with ultrasound, and small amounts of two different biocompatible polymers derived from poly(ethyleneglycol) (PEG). By adjusting the relative amounts of the two PEG-based polymers, the investigators found that they could create nanoparticles that were stable at room temperature but that at body temperature would eventually combine to create ultrasound-responsive microbubbles. The researchers also demonstrated that they could load therapeutic doses of doxorubicin, a potent anticancer drug, into these nanoparticles and that the drug remained entrapped when the transition from nanoparticles to microbubbles occurred.

When injected into tumor-bearing mice, the nanoparticles retain their size long enough to travel to tumors and seep out of the leaky blood vessels that surround solid tumors. Once in the tumors, the nanoparticles begin coalescing into larger microbubbles that are then readily visible using standard ultrasound imaging instruments. Once tumor imaging is complete, focused ultrasound is then directed at the tumors, triggering drug release within the tumors. In addition, ultrasound energy causes the microbubbles to explode, which can damage nearby cancer cell membranes and further enhance drug uptake. Tumor-bearing mice treated with these nanoparticles showed dramatic tumor regression after two treatments spread 1 week apart.

####

About National Cancer Institute
To help meet the goal of reducing the burden of cancer, the National Cancer Institute (NCI), part of the National Institutes of Health, is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat and prevent cancer.

The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.

Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.

For more information, please click here

Contacts:
National Cancer Institute
Office of Technology & Industrial Relations
ATTN: NCI Alliance for Nanotechnology in Cancer
Building 31, Room 10A49
31 Center Drive , MSC 2580
Bethesda , MD 20892-2580

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: